CVS Health Corporation (0HRS.L)
USD 69.27
(0.23%)
USD 69.27
(0.23%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 18.17 Billion USD | -7.65% |
| 2022 | 12.33 Billion USD | 1.47% |
| 2021 | 17.4 Billion USD | 6.02% |
| 2020 | 17.08 Billion USD | 12.6% |
| 2019 | 16.34 Billion USD | 27.85% |
| 2018 | 6.7 Billion USD | 7.47% |
| 2017 | 11.84 Billion USD | -10.85% |
| 2016 | 12.21 Billion USD | 16.54% |
| 2015 | 11.54 Billion USD | 7.45% |
| 2014 | 10.74 Billion USD | 8.46% |
| 2013 | 9.91 Billion USD | 6.2% |
| 2012 | 8.63 Billion USD | 18.12% |
| 2011 | 7.9 Billion USD | 3.46% |
| 2010 | 7.63 Billion USD | -2.47% |
| 2009 | 7.83 Billion USD | 6.92% |
| 2008 | 7.34 Billion USD | 24.33% |
| 2007 | 5.88 Billion USD | 85.45% |
| 2006 | 3.17 Billion USD | 21.71% |
| 2005 | 2.6 Billion USD | 33.67% |
| 2004 | 1.9 Billion USD | 185.56% |
| 2003 | 683.4 Million USD | -54.94% |
| 2002 | 1.51 Billion USD | -15.58% |
| 2001 | 1.44 Billion USD | 10.94% |
| 2000 | 1.61 Billion USD | 14.57% |
| 1999 | 1.41 Billion USD | 5.6% |
| 1998 | 1.18 Billion USD | 2.07% |
| 1997 | 946.7 Million USD | 328.14% |
| 1996 | 867.5 Million USD | -77.46% |
| 1995 | 723.9 Million USD | 66.62% |
| 1994 | 817 Million USD | 0.32% |
| 1993 | 814.9 Million USD | 45.01% |
| 1992 | 561.9 Million USD | -30.63% |
| 1991 | 808.1 Million USD | 3.79% |
| 1990 | 778.6 Million USD | 2.62% |
| 1989 | 758.7 Million USD | 12.94% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 3.01 Billion USD | -24.18% |
| 2024 Q2 | 4.38 Billion USD | 22.89% |
| 2023 Q1 | 4.53 Billion USD | -5.19% |
| 2023 Q4 | 4.57 Billion USD | -1.57% |
| 2023 FY | - USD | -7.65% |
| 2023 Q3 | 4.64 Billion USD | -1.53% |
| 2023 Q2 | 4.71 Billion USD | 4.13% |
| 2022 Q1 | 4.95 Billion USD | 36.58% |
| 2022 FY | - USD | 1.47% |
| 2022 Q4 | 4.77 Billion USD | 3.17% |
| 2022 Q2 | 5.6 Billion USD | 13.23% |
| 2022 Q3 | 4.63 Billion USD | -17.39% |
| 2021 Q1 | 4.75 Billion USD | 84.44% |
| 2021 Q3 | 4.67 Billion USD | -15.12% |
| 2021 FY | - USD | 6.02% |
| 2021 Q4 | 3.62 Billion USD | -22.46% |
| 2021 Q2 | 5.5 Billion USD | 15.88% |
| 2020 Q3 | 4.41 Billion USD | -24.2% |
| 2020 FY | - USD | 12.6% |
| 2020 Q1 | 4.59 Billion USD | 49.87% |
| 2020 Q2 | 5.82 Billion USD | 26.73% |
| 2020 Q4 | 2.57 Billion USD | -41.66% |
| 2019 Q4 | 3.06 Billion USD | -24.27% |
| 2019 FY | - USD | 27.85% |
| 2019 Q1 | 3.83 Billion USD | 25.11% |
| 2019 Q2 | 4.43 Billion USD | 15.74% |
| 2019 Q3 | 4.05 Billion USD | -8.66% |
| 2018 Q4 | 3.06 Billion USD | -4.07% |
| 2018 FY | - USD | 7.47% |
| 2018 Q3 | 3.19 Billion USD | 0.03% |
| 2018 Q1 | 2.59 Billion USD | -16.67% |
| 2018 Q2 | 3.19 Billion USD | 23.24% |
| 2017 Q2 | 2.73 Billion USD | 13.52% |
| 2017 Q4 | 3.1 Billion USD | 6.18% |
| 2017 Q3 | 2.92 Billion USD | 6.94% |
| 2017 FY | - USD | -10.85% |
| 2017 Q1 | 2.41 Billion USD | -19.5% |
| 2016 FY | - USD | 16.54% |
| 2016 Q3 | 3.43 Billion USD | 15.47% |
| 2016 Q2 | 2.97 Billion USD | 6.25% |
| 2016 Q1 | 2.79 Billion USD | 2.53% |
| 2016 Q4 | 2.99 Billion USD | -12.76% |
| 2015 Q2 | 2.75 Billion USD | 4.95% |
| 2015 FY | - USD | 7.45% |
| 2015 Q3 | 2.87 Billion USD | 4.17% |
| 2015 Q4 | 2.72 Billion USD | -4.91% |
| 2015 Q1 | 2.62 Billion USD | -6.72% |
| 2014 FY | - USD | 8.46% |
| 2014 Q3 | 2.72 Billion USD | 1.07% |
| 2014 Q2 | 2.69 Billion USD | 7.92% |
| 2014 Q4 | 2.81 Billion USD | 3.15% |
| 2014 Q1 | 2.5 Billion USD | -6.5% |
| 2013 Q4 | 2.67 Billion USD | 23.79% |
| 2013 Q2 | 2.41 Billion USD | 9.81% |
| 2013 FY | - USD | 6.2% |
| 2013 Q1 | 2.2 Billion USD | -16.91% |
| 2013 Q3 | 2.16 Billion USD | -10.63% |
| 2012 Q3 | 2.25 Billion USD | 5.56% |
| 2012 Q2 | 2.13 Billion USD | 17.01% |
| 2012 Q1 | 1.82 Billion USD | -22.34% |
| 2012 FY | - USD | 18.12% |
| 2012 Q4 | 2.65 Billion USD | 17.36% |
| 2011 Q3 | 1.99 Billion USD | 5.84% |
| 2011 Q1 | 1.68 Billion USD | -21.36% |
| 2011 Q4 | 2.35 Billion USD | 18.17% |
| 2011 FY | - USD | 3.46% |
| 2011 Q2 | 1.88 Billion USD | 11.63% |
| 2010 Q1 | 1.76 Billion USD | -21.32% |
| 2010 Q4 | 2.14 Billion USD | 15.64% |
| 2010 Q3 | 1.85 Billion USD | 23.52% |
| 2010 Q2 | 1.5 Billion USD | -15.15% |
| 2010 FY | - USD | -2.47% |
| 2009 Q1 | 1.73 Billion USD | -16.91% |
| 2009 FY | - USD | 6.92% |
| 2009 Q4 | 2.24 Billion USD | 20.41% |
| 2009 Q3 | 1.86 Billion USD | 16.72% |
| 2009 Q2 | 1.59 Billion USD | -7.69% |
| 2008 FY | - USD | 24.33% |
| 2008 Q4 | 2.08 Billion USD | 17.37% |
| 2008 Q1 | 1.66 Billion USD | -4.71% |
| 2008 Q3 | 1.77 Billion USD | -0.62% |
| 2008 Q2 | 1.78 Billion USD | 7.11% |
| 2007 Q4 | 1.75 Billion USD | 11.39% |
| 2007 Q3 | 1.57 Billion USD | -2.78% |
| 2007 FY | - USD | 85.45% |
| 2007 Q2 | 1.61 Billion USD | 71.14% |
| 2007 Q1 | 945.3 Million USD | -0.57% |
| 2006 Q1 | 715.9 Million USD | -5.68% |
| 2006 Q2 | 778.1 Million USD | 8.69% |
| 2006 Q3 | 730.2 Million USD | -6.16% |
| 2006 FY | - USD | 21.71% |
| 2006 Q4 | 950.7 Million USD | 30.2% |
| 2005 FY | - USD | 33.67% |
| 2005 Q4 | 759 Million USD | 29.39% |
| 2005 Q3 | 586.6 Million USD | -6.19% |
| 2005 Q2 | 625.3 Million USD | -1.94% |
| 2005 Q1 | 637.7 Million USD | 19.29% |
| 2004 FY | - USD | 185.56% |
| 2004 Q3 | 434.6 Million USD | -10.08% |
| 2004 Q4 | 534.6 Million USD | 23.01% |
| 2004 Q2 | 483.3 Million USD | -3.15% |
| 2004 Q1 | 499 Million USD | 189.85% |
| 2003 Q3 | 402.5 Million USD | -4.71% |
| 2003 FY | - USD | -54.94% |
| 2003 Q2 | 422.4 Million USD | 2.05% |
| 2003 Q4 | -555.4 Million USD | -237.99% |
| 2003 Q1 | 413.9 Million USD | -0.1% |
| 2002 Q1 | 371.5 Million USD | 42.45% |
| 2002 Q3 | 353.6 Million USD | -6.23% |
| 2002 FY | - USD | -15.58% |
| 2002 Q4 | 414.3 Million USD | 17.17% |
| 2002 Q2 | 377.1 Million USD | 1.51% |
| 2001 Q2 | 422.2 Million USD | -8.22% |
| 2001 FY | - USD | 10.94% |
| 2001 Q1 | 460 Million USD | 3.23% |
| 2001 Q3 | 300.9 Million USD | -28.73% |
| 2001 Q4 | 260.8 Million USD | -13.33% |
| 2000 FY | - USD | 14.57% |
| 2000 Q1 | 406.7 Million USD | 0.79% |
| 2000 Q3 | 359.7 Million USD | -11.69% |
| 2000 Q4 | 445.6 Million USD | 23.88% |
| 2000 Q2 | 407.3 Million USD | 0.15% |
| 1999 Q3 | 289.8 Million USD | -19.25% |
| 1999 Q1 | 361.2 Million USD | 9.12% |
| 1999 Q2 | 358.9 Million USD | -0.64% |
| 1999 Q4 | 403.5 Million USD | 39.23% |
| 1999 FY | - USD | 5.6% |
| 1998 Q2 | 294.1 Million USD | 61.59% |
| 1998 Q4 | 331 Million USD | 31.09% |
| 1998 FY | - USD | 2.07% |
| 1998 Q1 | 281.2 Million USD | 7.49% |
| 1998 Q3 | 252.5 Million USD | -44.43% |
| 1997 Q3 | 201 Million USD | -66.35% |
| 1997 FY | - USD | 328.14% |
| 1997 Q1 | 245.6 Million USD | -24.86% |
| 1997 Q2 | 160.5 Million USD | 450.51% |
| 1997 Q4 | 261.6 Million USD | 30.15% |
| 1996 Q4 | 163.7 Million USD | 195.3% |
| 1996 Q3 | 74.5 Million USD | 97.98% |
| 1996 Q2 | 213.3 Million USD | -58.76% |
| 1996 Q1 | 62.6 Million USD | -66.1% |
| 1996 FY | - USD | -77.46% |
| 1995 Q3 | 83 Million USD | -40.24% |
| 1995 FY | - USD | 66.62% |
| 1995 Q4 | 176.7 Million USD | 112.89% |
| 1995 Q2 | 139.1 Million USD | 486.08% |
| 1995 Q1 | 23.7 Million USD | -94.85% |
| 1994 Q3 | 157.1 Million USD | 11.06% |
| 1994 FY | - USD | 0.32% |
| 1994 Q2 | 141.2 Million USD | 138.18% |
| 1994 Q1 | 59.4 Million USD | -87.19% |
| 1994 Q4 | 460.6 Million USD | 193.68% |
| 1993 Q2 | 195.8 Million USD | 914.51% |
| 1993 FY | - USD | 45.01% |
| 1993 Q1 | 19.5 Million USD | -89.51% |
| 1993 Q4 | 463.8 Million USD | 241.11% |
| 1993 Q3 | 135.5 Million USD | -30.8% |
| 1992 Q2 | 193.5 Million USD | 559.73% |
| 1992 Q3 | 154.4 Million USD | -20.23% |
| 1992 FY | - USD | -30.63% |
| 1992 Q4 | 184.3 Million USD | 19.33% |
| 1992 Q1 | 29.9 Million USD | -93.74% |
| 1991 Q4 | 467.9 Million USD | 209.66% |
| 1991 FY | - USD | 2.51% |
| 1991 Q1 | 42.2 Million USD | -89.27% |
| 1991 Q2 | 151.2 Million USD | 238.68% |
| 1991 Q3 | 146.8 Million USD | -1.95% |
| 1990 Q4 | 421.2 Million USD | 185.46% |
| 1990 Q3 | 146.2 Million USD | -12.38% |
| 1990 Q2 | 167.5 Million USD | 280.27% |
| 1990 FY | - USD | 2.76% |
| 1990 Q1 | 43.4 Million USD | -89.24% |
| 1989 Q1 | 66.3 Million USD | 101.73% |
| 1989 Q3 | 149.1 Million USD | 13.69% |
| 1989 Q2 | 130.8 Million USD | 96.89% |
| 1989 FY | - USD | 13.38% |
| 1989 Q4 | 412.5 Million USD | 174.39% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Phreesia, Inc. | -102.94 Million USD | 17757.973% |
| Accuray Incorporated | 9 Million USD | -201676.002% |
| Align Technology, Inc. | 799.03 Million USD | -2174.983% |
| Elevance Health Inc. | 10.49 Billion USD | -73.289% |
| AxoGen, Inc. | -13.32 Million USD | 136489.556% |
| Boston Scientific Corporation | 3.61 Billion USD | -403.128% |
| Cardinal Health, Inc. | 1.97 Billion USD | -819.009% |
| Centene Corporation | -463 Million USD | 4026.134% |
| DaVita Inc. | 2.34 Billion USD | -674.704% |
| HCA Healthcare, Inc. | 12.72 Billion USD | -42.898% |
| Hologic, Inc. | 1.29 Billion USD | -1302.407% |
| Humana Inc. | -561 Million USD | 3340.285% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | -1392.857% |
| Laboratory Corporation of America Holdings | 1.34 Billion USD | -1247.117% |
| Masimo Corporation | 236.7 Million USD | -7579.763% |
| McKesson Corporation | 4.66 Billion USD | -289.501% |
| Patterson Companies, Inc. | 374.75 Million USD | -4750.623% |
| Quest Diagnostics Incorporated | 1.73 Billion USD | -949.538% |
| ResMed Inc. | 1.6 Billion USD | -1035.891% |
| Henry Schein, Inc. | 943 Million USD | -1827.678% |
| Teladoc Health, Inc. | 153.99 Million USD | -11704.126% |
| Universal Health Services, Inc. | 1.74 Billion USD | -942.662% |
| Veeva Systems Inc. | 429.33 Million USD | -4134.0% |
| Baxter International Inc. | 2.77 Billion USD | -554.827% |
| Becton, Dickinson and Company | 4.27 Billion USD | -325.216% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | -659.283% |
| Danaher Corporation | 7.49 Billion USD | -142.406% |
| Stryker Corporation | 5.16 Billion USD | -252.287% |
| Medtronic plc | 9.05 Billion USD | -100.729% |